One example of the power of this technology is a study that utilized CRISPR/Cas9 to modify APOE3 alleles in iPSCs from a healthy individual to APOE4, with APOE4 allele being the most significant AD risk gene [400]. This evidence concerns the gene APOE and Alzheimer disease.